Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alignment Healthcare, Inc.'s SEC filings document a Medicare Advantage operating company with common stock listed on Nasdaq under ALHC. Its Form 8-K reports furnish quarterly and annual operating results, health plan membership, revenue, adjusted gross profit, adjusted EBITDA, guidance updates and Regulation FD materials related to strategy, market position and Medicare Advantage quality ratings.
Proxy materials cover board elections, executive compensation, equity awards, pay-versus-performance data and shareholder voting matters. Registration statements, prospectus supplements and underwriting agreements describe secondary offerings of common stock by selling stockholders, the company's capital structure and related securities-law obligations.
FMR LLC (parent of Fidelity Investments) and its chair Abigail P. Johnson filed Amendment No. 4 to Schedule 13G reporting a passive stake in Alignment Healthcare (ALHC).
- Shares owned: 11,279,800.70 common shares.
- Percent of class: 5.7 % as of the event date 30 Jun 2025.
- Voting power: FMR holds sole voting power over 11,277,456.23 shares; Johnson reports no direct voting power.
- Dispositive power: FMR and Johnson each have sole dispositive power over the full 11.28 m shares; no shared powers are disclosed.
The filing is made under Rule 13d-1(b)/(c), confirming the stake is held in the ordinary course of business with no intent to influence control. The signature is dated 5 Aug 2025 and executed by Richard Bourgelas under existing power of attorney.
Crossing the 5 % threshold positions Fidelity as a significant institutional shareholder, potentially broadening ALHC’s investor base and adding passive support to the stock’s float; however, the filing provides no insight into future trading intentions.
Form 4 filing for Alignment Healthcare (ALHC) shows Director Joseph S. Konowiecki sold 25,000 common shares on 31 Jul 2025 at $16.00 per share under a pre-arranged Rule 10b5-1 trading plan adopted 5 Mar 2025. Gross proceeds equal roughly $400k.
Following the sale, Konowiecki’s direct ownership stands at 1,152,049 shares. No derivative securities were reported. The transaction does not alter board status and no other insider activity is disclosed in this filing.
Alignment Healthcare, Inc. (ALHC) — Form 144 filing
An insider intends to sell up to 25,000 common shares (≈0.013% of the 198,031,417 shares outstanding) through broker Justin Tabit on or about 31 Jul 2025. The shares, valued at an estimated $398,750, were originally received on 6 Oct 2014 as equity awards from Joseph Konowiecki. No related sales have been made in the past three months. The filer confirms possession of no undisclosed material adverse information and notes potential reliance on a Rule 10b5-1 trading plan.